Two Surprising FDA Rejections Raise Alarms for Biotech Investors

(Bloomberg) -- The Food and Drug Administration’s rejection of a pair of medicines that Wall Street expected to sail by regulators raised concerns that other upcoming drug decisions could meet a si...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.